Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries
The University of Queensland · Aarhus University · +40 more institutions
Abstract
Information on the frequency and timing of mental disorder onsets across the lifespan is of fundamental importance for public health planning. Broad, cross-national estimates of this information from coordinated general population surveys were last updated in 2007. We aimed to provide updated and improved estimates of age-of-onset distributions, lifetime prevalence, and morbid risk.
In this cross-national analysis, we analysed data from respondents aged 18 years or older to the World Mental Health surveys, a coordinated series of cross-sectional, face-to-face community epidemiological surveys administered between 2001 and 2022. In the surveys, the WHO Composite International Diagnostic Interview, a fully structured psychiatric diagnostic interview, was used to assess age of onset, lifetime prevalence, and morbid risk of 13 DSM-IV mental disorders until age 75 years across surveys by sex. We did not assess ethnicity. The surveys were geographically clustered and weighted to adjust for selection probability, and standard errors of incidence rates and cumulative incidence curves were calculated using the jackknife repeated replications simulation method, taking weighting and geographical clustering of data into account.
Citation impact
- FWCI
- 169.53
- Percentile
- 100%
- References
- 31
Authors
86- JJJohn J. McGrathCorresponding
The University of Queensland, Aarhus University, Queensland Centre for Mental Health Research
- AAAli Al-Hamzawi
University of Al-Qadisiyah
- JAJordi Alonso
Universitat Pompeu Fabra, Centro de Investigación Biomédica en Red, Hospital Del Mar, Hospital del Mar Research Institute
- YAYasmin Altwaijri
King Faisal Specialist Hospital & Research Centre
- LHLaura Helena Andrade
Universidade de São Paulo
Topics & keywords
- Population
- MEDLINE
- Medicine
- Psychiatry
- Demography
- Psychology
- Environmental health
- Political science
- No poverty
Funding
- RWRobert Wood Johnson FoundationAward: 044708
- JDJohn D. and Catherine T. MacArthur FoundationAwards: R01 DA016558, R13-MH066849
- JWJohn W. Alden Trust
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- WHWorld Health Organization
- UOUniversity of Michigan
- HMHamad Medical Corporation
- IIndivior
- AGAustralian Government
- KCKowa Company
- UCUniversidad CES
- MOMinistry of Health – Kingdom of Saudi Arabia
- ECEuropean CommissionAwards: EAHC 20081308, 20081308, QLG5-1999-01042, 2004123, SANCO 2004123
- PHPublic Health Agency
- FDFundação de Amparo à Pesquisa do Estado de São PauloAwards: 03/00204-3, 03/00204-
- FNFonds National de la Recherche Luxembourg
- KFKing Faisal Specialist Hospital and Research Centre
- KSKing Saud University
- GDGeneralitat de CatalunyaAwards: 01042, 2014 SGR 748, 2017 SGR 452, 2017 SGR
- BFBundesministerium für Gesundheit
- NINational Insurance Institute of Israel
- MDMinisterio de Salud de la NaciónAward: 2002-17270/13-5
- MOMinistry of Health, Labour and WelfareAward: H25-SEISHIN-IPPAN-006
- CNConselho Nacional de Desenvolvimento Científico e TecnológicoAward: 307933/2019-9
- QUQatar University
- KAKing Abdulaziz City for Science and Technology
- UDUniversidade de Lisboa
- MDMinisterio de Ciencia y TecnologíaAward: SAF 2000-158-CE
- MOMinistry of Health, State of Israel
- SBSaudi Basic Industries Corporation
- FPFundación para la Formación e Investigación Sanitarias de la Región de Murcia
- SMServicio Murciano de Salud
- RPRegione PiemonteAward: 00/0028
- FMFakultet Medicinskih Nauka, Univerziteta U Kragujevcu
- SServier
- HLH. Lundbeck A/S
- FCFundação ChampalimaudAward: R01 MH070884
- MDMinisterio de Salud
- MZMinisterstwo Zdrowia
- KSKing Salman Center for Disability Research
- SSeqirus
- SASubstance Abuse and Mental Health Services Administration
- UPU.S. Public Health ServiceAwards: R01 DA016558, R01-MH069864, R13-MH066849
- PFPfizer FoundationAwards: R01-MH069864, R01 DA016558, R13-MH066849, R03-TW006481
- QNQatar National Research Fund
- PAPan American Health Organization
- MRMedical Research Council
- EAExecutive Agency for Health and Consumers
- FPFundação para a Ciência e a Tecnologia
- IDInstituto de Salud Carlos IIIAwards: CB06/02/0046, RETICS RD06/0011, RD06/0011, FIS 00/0028, CIBER CB06/02/0046
- CDConsejería de Sanidad y Política Social, Comunidad Autónoma de la Región de Murcia
- HAHealth and Social Care Research and Development Division
- NINational Institute of Mental HealthAwards: U01-MH60220, R01-MH069864, MH60220, MH070884, R01 MH070884, R13-MH066849
- NINational Institute on Drug AbuseAward: R01 DA016558
- FIFogarty International CenterAwards: R03-TW006481, R03 TW006481-01, FIRCA R03-TW006481